CYTOTROPH Trademark

Trademark Overview


On Friday, February 4, 2022, a trademark application was filed for CYTOTROPH with the United States Patent and Trademark Office. The USPTO has given the CYTOTROPH trademark a serial number of 97253130. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 18, 2024. This trademark is owned by Obsidian Therapeutics, Inc.. The CYTOTROPH trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Custom manufacture of cells for medical or clinical use for others; Custom manufacture of pharmaceutical preparations for others in the fields of cell therapy, gene therapy, regenerative medicine and biopharmaceuticals; Custom manufacture of biological preparations for others for the treatment of cancer

Cells for medical or clinical use; Pharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, and immunotherapy for the prevention and treatment of cancer, cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders; Biological preparations for the treatment of cancer

Cells in the nature of biological tissue cultures for scientific, laboratory or medical research

Medical and scientific research and development services in the fields of cell therapy, gene therapy, oncology, and immunotherapy
cytotroph

General Information


Serial Number97253130
Word MarkCYTOTROPH
Filing DateFriday, February 4, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements


Goods and ServicesCustom manufacture of cells for medical or clinical use for others; Custom manufacture of pharmaceutical preparations for others in the fields of cell therapy, gene therapy, regenerative medicine and biopharmaceuticals; Custom manufacture of biological preparations for others for the treatment of cancer
Goods and ServicesCells for medical or clinical use; Pharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, and immunotherapy for the prevention and treatment of cancer, cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders; Biological preparations for the treatment of cancer
Goods and ServicesCells in the nature of biological tissue cultures for scientific, laboratory or medical research
Goods and ServicesMedical and scientific research and development services in the fields of cell therapy, gene therapy, oncology, and immunotherapy

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, February 9, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateWednesday, February 9, 2022
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 9, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameObsidian Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Party NameObsidian Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events


Event DateEvent Description
Monday, March 18, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 18, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 3, 2023SOU EXTENSION 1 GRANTED
Monday, July 3, 2023SOU EXTENSION 1 FILED
Monday, July 3, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 17, 2022ASSIGNED TO EXAMINER
Wednesday, February 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 8, 2022NEW APPLICATION ENTERED